Jul 26 2024 58 mins 2
On June 27, 2024 we discussed AI in Life Sciences with Jot Chahal, Johnson & Johnson, Patricia Leuchten, Diligent Pharma and V. "Bala" Balasubramanian, PhD, MBA, Orion Innovation
Jot Chahal is Vice President, Global Digital Health at Johnson & Johnson Innovative Medicine, where he is accelerating the commercialization of digital health assets across the pharmaceutical business.
Partnering with our regions, technology, and R&D leaders across the globe to build digital health (SaMD, DTx) capabilities and drive business growth across all therapy areas.
He is an entrepreneurial and results-driven health technology executive with twenty years of experience in driving top-line profitable growth through innovation, and data-driven strategies across industries, services, and markets globally.
Patti Leuchten is a pharma industry leader and entrepreneur with a focus on driving improvements in clinical trial execution, at scale, through innovative solutions.
In 1999, she founded The Avoca Group, whose Avoca Quality Consortium paved the way for Diligent Pharma and the Diligent Qualification Platform.
Dr. V. “Bala” Balasubramanian is currently SVP and Global Head of Industry Solutions Group for Healthcare and Life Sciences at Orion Innovation.
He is responsible for defining the GTM strategy, solution and service offerings for the HLS division, exploring digital transformation initiatives to further the needs of clients, and providing thought leadership to the industry.
It has resulted in Orion being featured in Gartner and Everest Peak Matrix Benchmark Reports in 2022 and 2023. He has recently written about opportunities and challenges with respect to GenAI in Life Sciences.
Prior to Orion, Bala was the Co-Founder and CEO of Cabeus where he was responsible for strategy, leadership and vision for both service offerings and a cloud platform to transform the regulatory value chain for Life Sciences.
#ai #drugdiscovery #clinicaltrials
#podcast #AFewThingsPodcast
